Prognosis and survival for laryngeal cancer

If you have laryngeal cancer, you may have questions about your prognosis. A prognosis is the doctor’s best estimate of how cancer will affect someone and how it will respond to treatment. Prognosis and survival depend on many factors. Only a doctor familiar with your medical history, the type, stage and characteristics of your cancer, the treatments chosen and the response to treatment can put all of this information together with survival statistics to arrive at a prognosis.

A prognostic factor is an aspect of the cancer or a characteristic of the person (such as whether they smoke or drink alcohol) that the doctor will consider when making a prognosis. A predictive factor influences how a cancer will respond to a certain treatment. Prognostic and predictive factors are often discussed together. They both play a part in deciding on a treatment plan and a prognosis.

The following are prognostic and predictive factors for laryngeal cancer.


The stage of laryngeal cancer includes the size of the tumour and how far it has grown into other tissues around the larynx. An earlier stage cancer has a better prognosis than one that is diagnosed at a later stage.

Location of the tumour

Cancer that starts in the glottis has a better prognosis than if the cancer starts elsewhere in the larynx.

Spread to the lymph nodes

Cancer that hasn’t spread to the lymph nodes in the neck has a better prognosis than cancer that has spread to the lymph nodes. The prognosis is better if the lymph nodes with the cancer are small and if the cancer has spread to lymph nodes on only one side of the neck.

Depth of tumour growth

Tumours that grow inward and deeper into the tissues of the larynx have a poorer prognosis than tumours that grow along the surface of the larynx.

Your general health

Your general health – including your performance status, your nutritional status, how well your lungs function and other health problems – has an effect on how well you will cope with treatment for cancer of the larynx.

People with a history of heavy tobacco and alcohol use tend to have other medical conditions (called comorbidities), such as liver cirrhosis, cardiovascular disease, lung problems and poor nutritional status. People with these types of conditions may not be able to cope with the standard treatments. This influences treatment outcomes.

Smoking during radiation therapy can cause side effects or make them worse and can therefore affect how successful the treatment will be. If smoking and drinking alcohol continues during treatment, side effects of treatment can be worse. This can cause treatment delays and affect the outcome of treatment.

Tumour grade

In general, higher grade tumours tend to spread (metastasize) more readily than lower grade tumours and have a poorer prognosis.

Expert review and references

  • American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 7th ed. Chicago: Springer; 2010.
  • Bourhis, J . Oral cavity, pharynx and larynx cancer. Gospodarowicz, M. K., O'Sullivan, B., Sobin, L. H., et al. (Eds.). Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2006: 7: pp. 99-104.
  • National Cancer Institute. Laryngeal Cancer Treatment for Health Professionals (PDQ®). 2016:

Survival statistics for laryngeal cancer

Survival for laryngeal cancer depends on the stage and the location of the tumour.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society